Cargando…
Immunological effect of tyrosine kinase inhibitors on the tumor immune environment in non-small cell lung cancer
Acquired resistance to tyrosine kinase inhibitors (TKIs) limits the duration of antitumor effects and impairs the survival of patients with oncogene-driven non-small cell lung cancer (NSCLC). At present, little is known about the immunomodulatory ability of TKIs during the entire treatment period, i...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988264/ https://www.ncbi.nlm.nih.gov/pubmed/35414830 http://dx.doi.org/10.3892/ol.2022.13285 |